These days, the United States pharmaceutical market only has 3 major weight loss drugs available: Xenical (orlistat), Meridia (sibutramine), and also Phentermine. Obese patients and many doctors alike are hoping for brand new and more effective weight loss pills to emerge. 2 brand new fat reduction pills currently being produced along with analyzed in Europe are rimonabant (Acomplia) as well as taranabant.

Rimonabant seemed like a promising brand new weight-loss pill, although the FDA became concerned about some really serious psychiatric side effects such as depression and suicidal tendencies. Taranabant, so much, is showing fewer and milder side effects even though both drugs work similarly and produce comparable weight-loss.

Both brand new weight loss pills affect the receptors in the body’s system that regulates elements including energy level, food consumption, metabolism as well as fear and anxiety. Up to now, the reason behind the variations in unwanted side effects is unknown.

Dosage might be a factor. Less taranabant is necessary to produce similar weight-loss. Taranabant and rimonabant also have slight differences in the way they interact with the receptors. It is unclear for now why there are fewer negative effects in one new weight loss pill and not the other person.

Acomplia, or rimonabant, is right now for sale in Europe, alpilean reviews bat (www.medicalmalpracticecanada.com) though it doesn’t seem as though this new fat reduction pill is likely to make the debut of its in the Country for awhile. Merck, the pharmaceutical company getting taranabant, seems optimistic that they will be able to file for FDA approval in the summer of 2008. Nevertheless, the trials aren’t over and it may be awhile before this new weight reduction pill is available stateside.

For a lot of obese patients, hope in the type of a new, effective fat reduction pill cannot come quickly enough. It is amazing that with all of the pharmaceuticals out available that you will find only three approved weight loss pills available.

The problem is that the part of obesity that can be handled by the person is directly regarding human behavior. The part of obesity that can’t be controlled just isn’t completely understood.

We are left in a conundrum of sorts. In case an individual is obese due to lack of proper nourishment and exercise, he or maybe she might be helped, but mainly if that individual is prepared to help him or even herself. If an individual has in earnest attempted to lose weight and cannot, than medical intervention might be necessary. Regrettably, every new weight loss pill that comes about seems to have potentially detrimental side effects. The FDA cannot be blamed for not letting the sale of drugs such as Rimonabant. The duty of the FDA is protecting the public from potentially harmful substances. In light of the deaths that occurred through the use of Fen-phen, the FDA has reason being gun shy.

Leave a Reply

Your email address will not be published.